A case for time to tumor progression (TTP) as the primary (1^o) efficacy endpoint in 1^st-line metastatic colorectal cancer (MCRC) therapy: Correlation of TTP and overall survival (OS)

L. L. Miller, Gary Elfring, G. Gruia, S. Hirawat, Jean‐Yves Douillard

DOI: 10.1200/jco.2004.22.14_suppl.3503

Journal of Clinical Oncology

Data up to Jan 2025

Published2004

Citations2

References0

Fields

Medicine Oncology Internal medicine

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

Loading...

A case for time to tumor progression (TTP) as the primary (1o) efficacy endpoint in… (2004) – Journal of Clinical Oncology | Metascience Observatory Explorer